Maraviroc (celsentri) in HIV treatment
Sacchi V. – Farmeconomia e percorsi terapeutici 2008; 9(4): 219-222. Edited by AdRes Health Economics & Outcomes Research
Telbivudine (sebivo) in patients with hepatitis B virus (HBV) chronic infection
Sacchi V. – Farmeconomia e percorsi terapeutici 2008; 9(4): 215-218. Edited by AdRes Health Economics & Outcomes Research
Usefulness and limitation of ddd and pdd analyses. 12 months of solid oral antipsychotics prescribing data for the nhs-reimbursed treatment of schizophrenia in Italy
Pradelli L. – Farmeconomia e percorsi terapeutici 2008; 9(4): 191-196
Daptomycin (cubicin) in patients with complicated skin or soft-tissue infections
Sacchi V. – Farmeconomia e percorsi terapeutici 2008; 9(3): 163-166. Edited by AdRes Health Economics & Outcomes Research
Entecavir (baraclude) in patients with chronic hepatitis B virus (HPV) infection
Sacchi V. – Farmeconomia e percorsi terapeutici 2008; 9(3): 157-161. Edited by AdRes Health Economics & Outcomes Research
Cost-efficacy analysis of hormonal treatments for advanced prostate cancer
Iannazzo S, Pradelli L. – Farmeconomia e percorsi terapeutici 2008; 9(3): 147-156
Budget impact of vildagliptin
Zaniolo O, Sacchi V, Pradelli L. – Farmeconomia e percorsi terapeutici 2008; 9(3): 137-146
Pharmacoeconomic analysis of valsartan for the treatment of chronic congestive heart failure in Italy
Iannazzo S, Pradelli L, Zaniolo O. – Farmeconomia e percorsi terapeutici 2008; 9(3): 125-135
Rotigotine patches (neupro) in early parkinson’s disease
Sacchi V. – Farmeconomia e percorsi terapeutici 2008; 9(2): 115-119. Edited by AdRes Health Economics & Outcomes Research
Natalizumab (tysabri) in multiple sclerosis patients
Sacchi V. – Farmeconomia e percorsi terapeutici 2008; 9(2): 109-114. Edited by AdRes Health Economics & Outcomes Research
Sartans: differences, similitudes and costs
Zaniolo O, Iannazzo S. – Farmeconomia e percorsi terapeutici 2008; 9(2): 69-88
Solifenacin in overactive bladder syndrome: pharmacoeconomic analysis
Iannazzo S, Pradelli L. – Farmeconomia e percorsi terapeutici 2008; 9(1): 5-14
Palonosetron in the prevention of chemotherapy-induced nausea and vomiting (cinv) in Italy: pharmacologic, clinical and economic aspects
Pradelli L, Eandi M. – Tumori 2008; 94: 26-32
Parnaparin: review of the literature
Pradelli L. – Farmeconomia e percorsi terapeutici 2008; 9(1): 27-40
La schizofrenia: percorsi diagnostico-terapeutici e costo di malattia
Zaniolo O, Pradelli L. – Profili in Farmacoeconomia 2008; 6
Economic evaluation of treatment with orlistat in italian obese patients
Iannazzo S, Zaniolo O, Pradelli L. – Curr Med Res Opin 2008; 24(1): 63-74
Palonosetron in the prevention of chemotherapy-induced nausea and vomiting (CINV) in Italy: pharmacologic, clinical and economic aspects
Pradelli L, Eandi M. – Tumori 2008; 94: 26-32
Profilo farmacologico, clinico ed economico dell’associazione fissa di beclometasone dipropionato e formoterolo in formulazione extra-fine nella terapia di pazienti con asma bronchiale
Cremonesi G, Pradelli L. – Profili in Farmacoeconomia 2008; 7
